145 related articles for article (PubMed ID: 21102472)
1. Growth inhibition properties of the putative prostate cancer biomarkers PSP94 and CRISP-3.
Van Eynde A; Litovkin K; Bollen M
Asian J Androl; 2011 Mar; 13(2):205-6. PubMed ID: 21102472
[No Abstract] [Full Text] [Related]
2. Growth inhibition mediated by PSP94 or CRISP-3 is prostate cancer cell line specific.
Pathak BR; Breed AA; Nakhawa VH; Jagtap DD; Mahale SD
Asian J Androl; 2010 Sep; 12(5):677-89. PubMed ID: 20676114
[TBL] [Abstract][Full Text] [Related]
3. Association of cysteine-rich secretory protein 3 and beta-microseminoprotein with outcome after radical prostatectomy.
Bjartell AS; Al-Ahmadie H; Serio AM; Eastham JA; Eggener SE; Fine SW; Udby L; Gerald WL; Vickers AJ; Lilja H; Reuter VE; Scardino PT
Clin Cancer Res; 2007 Jul; 13(14):4130-8. PubMed ID: 17634540
[TBL] [Abstract][Full Text] [Related]
4. Purification and characterization of CRISP-3 from human seminal plasma and its real-time binding kinetics with PSP94.
Anklesaria JH; Pandya RR; Pathak BR; Mahale SD
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Dec; 1039():59-65. PubMed ID: 27825912
[TBL] [Abstract][Full Text] [Related]
5. Effect of androgen deprivation therapy on the expression of prostate cancer biomarkers MSMB and MSMB-binding protein CRISP3.
Dahlman A; Edsjö A; Halldén C; Persson JL; Fine SW; Lilja H; Gerald W; Bjartell A
Prostate Cancer Prostatic Dis; 2010 Dec; 13(4):369-75. PubMed ID: 20680031
[TBL] [Abstract][Full Text] [Related]
6. Structural and molecular biology of PSP94: Its significance in prostate pathophysiology.
Anklesaria JH; Mhatre DR; Mahale SD
Front Biosci (Landmark Ed); 2018 Jan; 23(3):535-562. PubMed ID: 28930560
[TBL] [Abstract][Full Text] [Related]
7. beta-Microseminoprotein binds CRISP-3 in human seminal plasma.
Udby L; Lundwall A; Johnsen AH; Fernlund P; Valtonen-André C; Blom AM; Lilja H; Borregaard N; Kjeldsen L; Bjartell A
Biochem Biophys Res Commun; 2005 Jul; 333(2):555-61. PubMed ID: 15950934
[TBL] [Abstract][Full Text] [Related]
8. Cysteine-rich secretory protein 3 and β-microseminoprotein on prostate cancer needle biopsies do not have predictive value for subsequent prostatectomy outcome.
Hoogland AM; Dahlman A; Vissers KJ; Wolters T; Schröder FH; Roobol MJ; Bjartell AS; van Leenders GJ
BJU Int; 2011 Oct; 108(8):1356-62. PubMed ID: 21410630
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the prognostic significance of MSMB and CRISP3 in prostate cancer using automated image analysis.
Dahlman A; Rexhepaj E; Brennan DJ; Gallagher WM; Gaber A; Lindgren A; Jirström K; Bjartell A
Mod Pathol; 2011 May; 24(5):708-19. PubMed ID: 21240253
[TBL] [Abstract][Full Text] [Related]
10. Androgen receptor mediated epigenetic regulation of CRISP3 promoter in prostate cancer cells.
Pathak BR; Breed AA; Deshmukh P; Mahale SD
J Steroid Biochem Mol Biol; 2018 Jul; 181():20-27. PubMed ID: 29477539
[TBL] [Abstract][Full Text] [Related]
11. Mapping of the binding sites involved in PSP94-CRISP-3 interaction by molecular dissection of the complex.
Breed AA; Gomes A; Roy BS; Mahale SD; Pathak BR
Biochim Biophys Acta; 2013 Apr; 1830(4):3019-29. PubMed ID: 23375721
[TBL] [Abstract][Full Text] [Related]
12. Molecular cloning and gene expression analysis of PSP94 (prostate secretory protein of 94 amino acids) in primates.
Xuan JW; Wu D; Guo Y; Garde S; Shum DT; Mbikay M; Zhong R; Chin JL
DNA Cell Biol; 1997 May; 16(5):627-38. PubMed ID: 9174167
[TBL] [Abstract][Full Text] [Related]
13. Cysteine-rich secretory protein 3 plays a role in prostate cancer cell invasion and affects expression of PSA and ANXA1.
Pathak BR; Breed AA; Apte S; Acharya K; Mahale SD
Mol Cell Biochem; 2016 Jan; 411(1-2):11-21. PubMed ID: 26369530
[TBL] [Abstract][Full Text] [Related]
14. A model of the complex between human beta-microseminoprotein and CRISP-3 based on NMR data.
Ghasriani H; Fernlund P; Udby L; Drakenberg T
Biochem Biophys Res Commun; 2009 Jan; 378(2):235-9. PubMed ID: 19026612
[TBL] [Abstract][Full Text] [Related]
15. Seminal fluid: a useful source of prostate cancer biomarkers?
Roberts MJ; Richards RS; Gardiner RA; Selth LA
Biomark Med; 2015; 9(2):77-80. PubMed ID: 25689895
[No Abstract] [Full Text] [Related]
16. Identification of CRISP2 from human sperm as PSP94-binding protein and generation of CRISP2-specific anti-peptide antibodies.
Anklesaria JH; Kulkarni BJ; Pathak BR; Mahale SD
J Pept Sci; 2016 Jun; 22(6):383-90. PubMed ID: 27161017
[TBL] [Abstract][Full Text] [Related]
17. Characterization of the cysteine-rich secretory protein 3 gene as an early-transcribed gene with a putative role in the pathophysiology of Sjögren's syndrome.
Tapinos NI; Polihronis M; Thyphronitis G; Moutsopoulos HM
Arthritis Rheum; 2002 Jan; 46(1):215-22. PubMed ID: 11817594
[TBL] [Abstract][Full Text] [Related]
18. CRISP3 expression drives prostate cancer invasion and progression.
Volpert M; Furic L; Hu J; O'Connor AE; Rebello RJ; Keerthikumar S; Evans J; Merriner DJ; Pedersen J; Risbridger GP; McIntyre P; O'Bryan MK
Endocr Relat Cancer; 2020 Jul; 27(7):415-430. PubMed ID: 32357309
[TBL] [Abstract][Full Text] [Related]
19. Cysteine-rich secretory protein 3: inflammation role in adult varicocoele.
Belardin L; Camargo M; Intasqui P; Antoniassi M; Fraietta R; Bertolla R
Andrology; 2019 Jan; 7(1):53-61. PubMed ID: 30354034
[TBL] [Abstract][Full Text] [Related]
20. Is 37LRP cell surface receptor for PSP94?
Pathak BR; Jagtap DD; Mahale SD
Asian J Androl; 2011 Mar; 13(2):347. PubMed ID: 21297657
[No Abstract] [Full Text] [Related]
[Next] [New Search]
